Investigators compared measurement of reticulocyte hemoglobin content (CHr) with measurement of hemoglobin as a means of screening healthy infants for iron deficiency. Of 202 9- to 12-month-old infants initially enrolled in a prospective study, 23 (11.4%) had iron deficiency and six (3%) had iron deficiency and anemia, as gauged by transferrin saturation and hematologic parameters. From this initial group, 147 infants (none with anemia) were rescreened for iron deficiency at subsequent well-baby visits over a median of 5.6 months.
Infants who were iron-deficient, as well as those who were not, had significantly different values for all measured biochemical and hematologic markers of iron deficiency. Investigators identified a CHr threshold of <27.5 pg for detecting iron deficiency in infants at initial screening. Overall, reticulocyte hemoglobin content was more accurate than hemoglobin for detecting iron deficiency.
In addition, CHr <27.5 pg without anemia at initial screening was associated with anemia at screening a year later. Of 45 nonanemic infants with CHr <27.5 pg at initial screening, four developed anemia. But only one of the 102 nonanemic infants with CHr <27.5 or higher at initial screening was anemic at follow-up (Ullrich C et al: JAMA 2005;294:924).
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.